Elk Creek Partners’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$10.6M Buy
1,944,309
+2,275
+0.1% +$20.3K 1.81% 11
2019
Q4
$17.6M Sell
1,942,034
-342,298
-15% -$2.78M 2.02% 7
2019
Q3
$16.4M Buy
2,284,332
+115,522
+5% +$829K 1.41% 13
2019
Q2
$17.2M Buy
2,168,810
+335,917
+18% +$3.98M 1.29% 16
2019
Q1
$23.1M Buy
1,832,893
+94,887
+5% +$1.5M 1.66% 8
2018
Q4
$34.7M Buy
1,738,006
+172,275
+11% +$3.99M 2.88% 3
2018
Q3
$44.5M Sell
1,565,731
-95,675
-6% -$2.28M 2.4% 3
2018
Q2
$35M Sell
1,661,406
-684,257
-29% -$13M 1.92% 5
2018
Q1
$33.4M Buy
2,345,663
+364,583
+18% +$5.22M 1.95% 7
2017
Q4
$24.4M Buy
1,981,080
+807,257
+69% +$11.4M 1.43% 12
2017
Q3
$20.9M Buy
1,173,823
+275,086
+31% +$5.67M 1.32% 19
2017
Q2
$22.8M Sell
898,737
-90,123
-9% -$2.17M 1.48% 12
2017
Q1
$22.1M Buy
988,860
+40,077
+4% +$769K 1.35% 15
2016
Q4
$14M Buy
948,783
+447,244
+89% +$8.81M 0.95% 39
2016
Q3
$12.3M Buy
501,539
+31,039
+7% +$726K 0.81% 48
2016
Q2
$9.03M Sell
470,500
-97,668
-17% -$1.34M 0.64% 70
2016
Q1
$6M Buy
568,168
+210,756
+59% +$2.18M 0.44% 88
2015
Q4
$4.33M Buy
357,412
+39,862
+13% +$587K 0.31% 111
2015
Q3
$5.07M Buy
317,550
+99,414
+46% +$1.94M 0.41% 93
2015
Q2
$4.25M Buy
+218,136
New +$4.07M 0.38% 115

Other funds holding EVH

Elk Creek Partners's EVH Position: Q1 2020 in Review

Elk Creek Partners increased its Evolent Health (EVH) stake by 0.12% in Q1 2020, buying an estimated $20.3K and bringing the position to 1,944,309 shares worth $10.6M. The position accounts for 1.81% of the portfolio, ranked #11.

Elk Creek Partners first reported a position in EVH in Q2 2015 and has held it in 20 quarters since. The position peaked at $44.5M in Q3 2018. 154 funds tracked by Wall St. Rank hold EVH as of Q1 2020.

  • Elk Creek Partners held 1,944,309 shares of Evolent Health worth $10.6M as of Q1 2020.
  • Elk Creek Partners bought 2,275 Evolent Health shares in Q1 2020, an estimated $20.3K.
  • Evolent Health made up 1.81% of Elk Creek Partners's portfolio in Q1 2020, its #11 holding.
  • Elk Creek Partners first reported a position in Evolent Health in Q2 2015 and has held it in 20 quarters since.
  • Elk Creek Partners's Evolent Health position peaked at $44.5M in Q3 2018.
  • 154 funds tracked by Wall St. Rank held Evolent Health as of Q1 2020.

Based on Elk Creek Partners's 13F filing for Q1 2020, filed 14 May 2020.